ArticleBMC pregnancy and childbirth2026
Prevalence of maternal psychological disorders after immediate postpartum hemorrhage: a repeated nested cross-sectional survey in a cohort study.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03120208 (Prevalence of Psychological Disorders After Immediate Postpartum Hemorrhage), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Prevalence of Psychological Disorders After Immediate Postpartum Hemorrhage
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundPostpartum hemorrhage (PPH) remains a major cause of maternal morbidity worldwide. Few published studies have examined its psychological impact, and the scientific evidence is inadequate. Our principal objective was to assess whether the prevalence of depression at 2 months postpartum was greater among women with immediate PPH (≥ 500 mL) than among women without PPH. The secondary objectives were to describe at 6 and 12 months of the postpartum period the prevalence of depression, the mean depression score and the prevalence and mean scores for anxiety and PTSD at 2, 6 and 12 months postpartum among women with immediate PPH (≥ 500 mL) compared to women without PPH, and according to the type of delivery (cesarean or vaginal delivery).
methodsOur single-center cohort included women who gave birth at ≥ 22 weeks of gestation from April 27, 2017, through April 2, 2019. Self-administered questionnaires at M2, M6, and M12 have been used to assess the prevalence of depression (EPDS score ≥ 11), anxiety (GAD-7 score > 7) and PTSD (IES-R score ≥ 30). The results are expressed as percentages, least square means, and adjusted mean scores, for all deliveries and by type of birth (cesarean or not). The women with and without PPH were compared at each study time point (M2, M6, and M12).
resultsWe included 1,298 participants (PPH: n = 528; No-PPH: n = 770). The prevalence rate of depression was higher in the PPH group than in the No-PPH group among all the deliveries at M2 (24.4 vs. 18.2%; p = 0.03) It was greater at M12, in the case of a vaginal birth, in the No-PPH group than in the PPH group: 15.9% vs. 6.2% (p = 0.03). The adjusted mean score for depression was higher only at M6, for the vaginal births, among the women with no-PPH than among the women with PPH (6.9 vs. 5.5; p = 0.02). The anxiety prevalence and adjusted mean scores did not differ between the PPH and No-PPH groups for all deliveries and regardless of the type of birth at M2, M6 or M12. The prevalence of PTSD was higher at M2 in the PPH group compared to the No-PPH group (12.8% vs. 7.6%, p = 0.02). Among the cesarean births, women with PPH had a greater prevalence of PTSD than women without PPH at two months (15.4% vs. 4.6%; p = 0.02). The adjusted mean scores for PTSD were higher only at M2 and M12 among the cesarean births for women with PPH than for those without PPH: 11.0 vs. 6.5 (p = 0.005) and 10.6 vs. 5.8 (p = 0.02), respectively.
conclusionsPerinatal professionals must bear that these three postpartum psychological outcomes showed high levels of positive screening at all time points.
trial registrationThe study was registered at ClinicalTrials.gov NCT03120208, 27 April 2017.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.